Multicenter phase II study of sequential radioembolization-sorafenib therapy for inoperable hepatocellular carcinoma

Multicenter phase II study of sequential radioembolization-sorafenib therapy for inoperable hepatocellular carcinoma

10.1371/journal.pone.0090909

Saved in:

Bibliographic Details
Main Authors:	Chow, P.K.H., Poon, D.Y.H., Khin, M.-W., Singh, H., Han, H.-S., Goh, A.S.W., Choo, S.-P., Lai, H.-K., Lo, R.H.G., Tay, K.-H., Lim, T.-G., Gandhi, M., Tan, S.-B., Soo, K.-C.
Other Authors:	DUKE-NUS GRADUATE MEDICAL SCHOOL S'PORE
Format:	Article
Published:	2016
Online Access:	http://scholarbank.nus.edu.sg/handle/10635/124882
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

Similar Items

Radioembolization after portal vein embolization in a patient with multifocal hepatocellular carcinoma
by: Burgmans, M.C., et al.
Published: (2014)

Disease control and failure patterns of unresectable hepatocellular carcinoma following transarterial radioembolization with yttrium-90 microspheres and with/without sorafenib
by: Ajalaya Teyateeti, et al.
Published: (2022)

Radiation Dermatitis following Radioembolization for Hepatocellular Carcinoma: A Case for Prophylactic Embolization of a Patent Falciform Artery
by: Leong, Q.M., et al.
Published: (2014)

Non-target activity detection by post-radioembolization yttrium-90 PET/CT: Image assessment technique and case examples
by: Kao, Y.H., et al.
Published: (2016)

Radioembolization with infusion of yttrium-90 microspheres into a right inferior phrenic artery with hepatic tumor supply is feasible and safe
by: Burgmans, M.C., et al.
Published: (2014)

Single administration of Selective Internal Radiation Therapy versus continuous treatment with sorafeNIB in locally advanced hepatocellular carcinoma (SIRveNIB): Study protocol for a phase iii randomized controlled trial
by: Gandhi M., et al.
Published: (2018)

Treatment for hepatocellular carcinoma with portal vein tumor thrombosis: The emerging role for radioembolization using yttrium-90
by: Lau, W.-Y., et al.
Published: (2014)

Post-radioembolization yttrium-90 PET/CT-part 1: Diagnostic reporting
by: Kao, Y.-H., et al.
Published: (2014)

Image-guided personalized predictive dosimetry by artery-specific SPECT/CT partition modeling for safe and effective 90Y radioembolization
by: Kao, Y.H., et al.
Published: (2014)

AZD6244 enhances the anti-tumor activity of sorafenib in ectopic and orthotopic models of human hepatocellular carcinoma (HCC)
by: Huynh, H, et al.
Published: (2011)

Personalized predictive lung dosimetry by technetium-99m macroaggregated albumin SPECT/CT for yttrium-90 radioembolization
by: Kao, Y.H, et al.
Published: (2020)

Computed tomography hepatic arteriography has a hepatic falciform artery detection rate that is much higher than that of digital subtraction angiography and 99mTc-MAA SPECT/CT: Implications for planning 90Y radioembolization?
by: Burgmans, M.C., et al.
Published: (2014)

Post-radioembolization yttrium-90 PET/CT-part 2: Dose-response and tumor predictive dosimetry for resin microspheres
by: Kao, Y.-H., et al.
Published: (2014)

Survival outcomes of metastatic/unresectable hepatocellular carcinoma in patients treated with sorafenib
by: J. Chantharasamee, et al.
Published: (2020)

Randomized, open-label phase 2 study comparing frontline dovitinib versus sorafenib in patients with advanced hepatocellular carcinoma
by: Cheng A., et al.
Published: (2017)

Efficacy of sorafenib on metastatic renal cell carcinoma in Asian patients: Results from a multicenter study
by: Lu, J.J., et al.
Published: (2016)

Sorafenib induces growth suppression in mouse models of gastrointestinal stromal tumor
by: Huynh, H., et al.
Published: (2014)

AZD6244 and doxorubicin induce growth suppression and apoptosis in mouse models of hepatocellular carcinoma
by: Huynh, H, et al.
Published: (2020)

TLR3 agonist and Sorafenib combinatorial therapy promotes immune activation and controls hepatocellular carcinoma progression
by: Ho, V, et al.
Published: (2020)

Randomized, open-label phase 2 study comparing frontline dovitinib versus sorafenib in patients with advanced hepatocellular carcinoma
by: Ann Lii Cheng, et al.
Published: (2018)

Intra-Arterial Rhenium-188 Lipiodol in the Treatment of Inoperable Hepatocellular Carcinoma: Results of an IAEA-Sponsored Multination Study
by: Patricia Bernal, et al.
Published: (2018)

Combination of the ERK inhibitor AZD6244 and low-dose sorafenib in a xenograft model of human renal cell carcinoma
by: Yuen, J.S.P, et al.
Published: (2020)

Sorafenib efficacy in ovarian clear cell carcinoma revealed by transcriptome profiling
by: Matsumura, N., et al.
Published: (2014)

Hepatocellular carcinoma in Asia
by: Siddiqui, F.J., et al.
Published: (2014)

Synthesis and characterization of chitosan-based nanodelivery systems to enhance the anticancer effect of sorafenib drug in hepatocellular carcinoma and colorectal adenocarcinoma cells
by: Ruman, Umme, et al.
Published: (2022)

Conducting randomised controlled trials across countries with disparate levels of socio-economic development: The experience of the Asia-Pacific Hepatocellular Carcinoma Trials Group
by: Kong, N.H.Y., et al.
Published: (2014)

Adjuvant hepatic intra-arterial iodine-131-lipiodol following curative resection of hepatocellular carcinoma: A prospective randomized trial
by: Chung, A.Y.F., et al.
Published: (2014)

Phase II trial of docetaxel in Asian patients with inoperable stage III non-small cell lung cancer
by: Goh, B.C., et al.
Published: (2014)

Bevacizumab and rapamycin induce growth suppression in mouse models of hepatocellular carcinoma
by: Huynh, H., et al.
Published: (2012)

Bevacizumab and rapamycin induce growth suppression in mouse models of hepatocellular carcinoma
by: Huynh, H., et al.
Published: (2011)

Randomised double-blind trial of megestrol acetate vs placebo in treatment-naive advanced hepatocellular carcinoma
by: Chow, P.K.H., et al.
Published: (2014)

Endoscopic Nd:YAG laser treatment of inoperable lower gastrointestinal cancer
by: Tai, L.S., et al.
Published: (2016)

Image-guided high-dose-rate brachytherapy in inoperable endometrial cancer
by: P. Dankulchai, et al.
Published: (2018)

Experience with gemcitabine and cisplatin in the therapy of inoperable and metastatic cholangiocarcinoma
by: Chalyut Charoentum, et al.
Published: (2018)

Optimal operational adjustment in multi-functional energy systems in response to process inoperability
by: Kasivisvanathan, Harresh, et al.
Published: (2013)

Sequential representation of fuzzy similarity relations
by: Tan, S.K., et al.
Published: (2014)

P-graph approach to allocation of inoperability in urban infrastructure systems
by: Tan, Raymond Girard R., et al.
Published: (2015)

Impact estimation of flooding in Manila: An inoperability input-output approach
by: Yu, Krista Danielle S., et al.
Published: (2013)

A Shock absorption index for inoperability input-output models
by: Tan, Raymond Girard R., et al.
Published: (2015)

Synthesis and cytotoxicity study of magnetite nanoparticles coated with polyethylene glycol and sorafenib–zinc/aluminium layered double hydroxide
by: Ebadi, M., et al.
Published: (2021)